Assessment of Development of Resistance to Neuraminidase Inhibitors in A(h5n1) Influenza Viruses Using a Ferret Model

Grant number: 400595

Abstract

The neuraminidase (NA) inhibitors are considered the most effective anti-influenza drugs available for both prevention and treatment of influenza virus infection including A(H5N1) viruses. The drugs are effective against all subtypes of influenza A, making them ideal for use in the early months of a pandemic prior to an appropriate vaccine being produced. As a result many countries around the world, including Australia, have stockpiled these drugs (mainly Tamiflu) as part of their pandemic preparedness plans. However, of concern is the increasing number of recent reports of a higher than expected level of resistance in epidemic influenza being generated against these drugs. A recent isolatio..

View full description

Related publications (3)

Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model

AC Hurt, S Lowther, D Middleton, IG Barr

2010-09-01

Using an in vivo ferret model, we investigated the development of resistance to oseltamivir and zanamivir for two different influe..

In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses

AC Hurt, JK Holien, IG Barr

2009-10-01

To identify mutations that can arise in highly pathogenic A(H5N1) viruses under neuraminidase inhibitor selective pressure, two an..

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes

AC Hurt, P Selleck, N Komadina, R Shaw, L Brown, IG Barr

2007-03-01

Since 2003, highly pathogenic A(H5N1) influenza viruses have been the cause of large-scale death in poultry and the subsequent inf..

University of Melbourne Researchers

Lorena Brown